(2019) in Cell recently proposed that STK19 functions as an NRAS-activating kinase and that D89N represents a gain-of-function change, which increases STK19-mediated NRAS phosphorylation, thereby increasing the malignancy of NRAS-mutated melanomas (Yin et al., 2019). The gene discussed is NRAS; the disease is melanoma.